PD-RX Pharmaceuticals (PDRX) Ratios

1 Followers

PD-RX Pharmaceuticals Ratios

See a summary of PDRX’s cash flow.

Ratios	Jun 25	Jun 24	Jun 23	Jun 22
Liquidity Ratios
Current Ratio	―	6.34	4.97	6.71	6.44
Quick Ratio	―	5.27	3.99	5.75	5.45
Cash Ratio	―	3.68	2.37	4.03	2.94
Solvency Ratio	―	-0.06	-0.25	0.02	1.70
Operating Cash Flow Ratio	―	0.46	-0.59	1.05	1.74
Short-Term Operating Cash Flow Coverage	―	0.00	0.00	0.00	0.00
Net Current Asset Value	$ ―	$ 8.88M	$ 8.98M	$ 9.70M	$ 10.12M
Leverage Ratios
Debt-to-Assets Ratio	―	0.00	0.00	0.00	0.00
Debt-to-Equity Ratio	―	0.00	0.00	0.00	0.00
Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Long-Term Debt-to-Capital Ratio	―	0.00	0.00	0.00	0.00
Financial Leverage Ratio	―	1.17	1.23	1.15	1.16
Debt Service Coverage Ratio	―	0.00	0.00	0.00	0.00
Interest Coverage Ratio	―	0.00	0.00	0.00	0.00
Debt to Market Cap	―	0.00	0.00	0.00	0.00
Interest Debt Per Share	―	0.00	0.00	0.00	0.00
Net Debt to EBITDA	―	18.80	9.65	-556.43	-1.32
Profitability Margins
Gross Profit Margin	―	29.61%	29.68%	31.56%	38.52%
EBIT Margin	―	-2.60%	-3.76%	-0.60%	13.95%
EBITDA Margin	―	-1.79%	-2.96%	0.06%	14.39%
Operating Profit Margin	―	-2.60%	-5.02%	-0.90%	13.95%
Pretax Profit Margin	―	-1.52%	-3.76%	-0.60%	14.11%
Net Profit Margin	―	-1.40%	-3.98%	-0.46%	10.57%
Continuous Operations Profit Margin	―	-1.40%	-3.98%	-0.46%	10.57%
Net Income Per EBT	―	92.39%	105.78%	77.35%	74.86%
EBT Per EBIT	―	58.39%	74.82%	66.56%	101.21%
Return on Assets (ROA)	―	-2.15%	-5.86%	-0.76%	22.95%
Return on Equity (ROE)	―	-2.51%	-7.18%	-0.87%	26.73%
Return on Capital Employed (ROCE)	―	-4.63%	-8.99%	-1.69%	35.24%
Return on Invested Capital (ROIC)	―	-4.28%	-8.99%	-1.31%	26.38%
Return on Tangible Assets	―	-2.15%	-5.86%	-0.76%	22.95%
Earnings Yield	―	-6.92%	-13.09%	-1.00%	56.34%
Efficiency Ratios
Receivables Turnover	―	8.77	5.96	8.95	6.44
Payables Turnover	―	15.57	8.77	14.66	15.24
Inventory Turnover	―	7.20	5.97	8.88	9.61
Fixed Asset Turnover	―	14.34	13.19	13.96	23.19
Asset Turnover	―	1.53	1.47	1.64	2.17
Working Capital Turnover Ratio	―	2.04	2.02	2.15	3.24
Cash Conversion Cycle	―	68.89	80.79	57.02	70.66
Days of Sales Outstanding	―	41.63	61.23	40.79	56.64
Days of Inventory Outstanding	―	50.70	61.17	41.13	37.97
Days of Payables Outstanding	―	23.44	41.61	24.89	23.96
Operating Cycle	―	92.34	122.40	81.91	94.62
Cash Flow Ratios
Operating Cash Flow Per Share	―	0.50	-0.82	1.09	1.95
Free Cash Flow Per Share	―	0.49	-0.87	0.83	1.62
CapEx Per Share	―	<0.01	0.05	0.26	0.33
Free Cash Flow to Operating Cash Flow	―	1.00	1.06	0.76	0.83
Dividend Paid and CapEx Coverage Ratio	―	313.28	-17.33	4.19	5.88
Capital Expenditure Coverage Ratio	―	313.28	-17.33	4.19	5.88
Operating Cash Flow Coverage Ratio	―	0.00	0.00	0.00	0.00
Operating Cash Flow to Sales Ratio	―	0.04	-0.07	0.08	0.11
Free Cash Flow Yield	―	20.48%	-24.82%	13.89%	49.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-14.18	-7.64	-99.98	1.77
Price-to-Sales (P/S) Ratio	―	0.20	0.30	0.46	0.19
Price-to-Book (P/B) Ratio	―	0.36	0.55	0.87	0.47
Price-to-Free Cash Flow (P/FCF) Ratio	―	4.88	-4.03	7.20	2.01
Price-to-Operating Cash Flow Ratio	―	4.87	-4.26	5.48	1.66
Price-to-Earnings Growth (PEG) Ratio	―	0.22	-0.01	0.97	0.03
Price-to-Fair Value	―	0.36	0.55	0.87	0.47
Enterprise Value Multiple	―	7.45	-0.63	241.88	-0.02
Enterprise Value	―	-2.44M	353.01K	2.97M	-87.11K
EV to EBITDA	―	7.45	-0.63	241.88	-0.02
EV to Sales	―	-0.13	0.02	0.14	>-0.01
EV to Free Cash Flow	―	-3.20	-0.25	2.18	-0.03
EV to Operating Cash Flow	―	-3.19	-0.26	1.66	-0.03
Tangible Book Value Per Share	―	6.63	6.38	6.89	6.86
Shareholders’ Equity Per Share	―	6.63	6.38	6.89	6.85
Tax and Other Ratios
Effective Tax Rate	―	0.08	-0.06	0.23	0.25
Revenue Per Share	―	11.88	11.52	13.02	17.33
Net Income Per Share	―	-0.17	-0.46	-0.06	1.83
Tax Burden	―	0.92	1.06	0.77	0.75
Interest Burden	―	0.58	1.00	1.00	1.01
Research & Development to Revenue	―	0.00	0.00	0.00	0.00
SG&A to Revenue	―	0.32	0.34	0.32	0.24
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	-2.97	1.79	-18.24	1.07

Currency in USD